2022
DOI: 10.1136/heartjnl-2022-321972
|View full text |Cite
|
Sign up to set email alerts
|

Lipid lowering in primary prevention: time to focus on young patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
3
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(3 citation statements)
references
References 9 publications
0
3
0
Order By: Relevance
“…[22] Similar concerns have been expressed about statin under-treatment. [24] Lastly, this study highlights the importance of indicator choice in understanding control of hypertension. The difference between BLOOD_PRESSURE_CONTROLLED and the QOF derived HYPERTENSION_CONTROLLED indicators has been previously noted as reflecting missing recordings rather than reduction in control.…”
Section: Discussionmentioning
confidence: 80%
“…[22] Similar concerns have been expressed about statin under-treatment. [24] Lastly, this study highlights the importance of indicator choice in understanding control of hypertension. The difference between BLOOD_PRESSURE_CONTROLLED and the QOF derived HYPERTENSION_CONTROLLED indicators has been previously noted as reflecting missing recordings rather than reduction in control.…”
Section: Discussionmentioning
confidence: 80%
“…[25] Similar concerns have been expressed about statin under-treatment in younger patients. [27] Lastly, this study highlights the importance of indicator choice in assessing cohort-level management of hypertension. The difference between BLOOD_PRESSURE_CONTROLLED and the QOF derived HYPERTENSION_CONTROLLED indicators has been previously noted as reflecting missing recordings rather than reduction in control.…”
Section: Discussionmentioning
confidence: 84%
“…In the accompanying editorial, Hayek and Marquis-Gravel8 point out that ‘Because this study only includes patients who experienced a CV event, who still represent a minority of individuals <55 years old in the population, it does not inform us on a more global populational health perspective. Indeed, the risk of STEMI in young patients cannot be extrapolated from a series like this one because the denominator is unknown.’ Even so, ‘as clinicians, it is our duty to continue carefully screening and initiating primary prevention strategies even in our younger patients at high risk for cardiovascular diseases.’…”
mentioning
confidence: 99%